Evofem Biosciences Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits - News Summed Up

Evofem Biosciences Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits


Except as described below, the terms and provisions of the A&R Merger Agreement are consistent with the terms and provision of the Original Merger Agreement. The A&R Merger Agreement is subject to certain closing conditioned and contains customary representations, warranties and covenants and indemnifications provisions. The A&R Merger Agreement and the foregoing description thereof have been included to provide investors and stockholders with information regarding the terms of the A&R Merger Agreement. Investors and stockholders are not third-party beneficiaries under the A&R Merger Agreement. The Company expects to file a proxy statement with the SEC relating to the A&R Merger Agreement.


Source: Washington Post July 18, 2024 20:40 UTC



Loading...
Loading...
  

Loading...

                           
/* -------------------------- overlay advertisemnt -------------------------- */